Skip to main content
. Author manuscript; available in PMC: 2013 Oct 19.
Published in final edited form as: Neuropsychopharmacology. 2008 Jan 9;33(10):2505–2516. doi: 10.1038/sj.npp.1301643

Table 1.

Schedule of Testing

Time (min) Procedure
−90 Confirmation of abstinence from caffeine, alcohol, drugs, medications
Vital signs
Urine drug screen, urine pregnancy test
Placement of intravenous lines
−60 Behavioral assessments:
  PANSS
  CADSS
  VAS for “high,” “calm and relaxed,” and “anxiety”
Blood sampling: Δ-9-THC and THC-COOH
Vital signs
0 IV Δ-9-THC (0, 2.5, or 5 mg) over 2 min
+10 Vital signs: every 2 min (10 min) followed by every 5 min (20 min) and
then every 10 min
Behavioral assessments:
  PANSS
  CADSS
  VAS for “high,” “calm and relaxed,” and “anxiety”
Blood sampling: Δ-9-THC and THC-COOH
+30 Learning (immediate recall): HVLT
+45 Distractibility and vigilance: Gordon Box
+60 Delayed Free, cued, and recognition recall: HVLT
+80 Behavioral assessments:
  PANSS
  CADSS
  VAS for “high,” “calm and relaxed,” and “anxiety”
Blood sampling: Δ-9-THC and THC-COOH
+140 Blood sampling: Δ-9-THC and THC-COOH
+200 Behavioral assessments:
  PANSS
  CADSS
  VAS for “high,” “calm and relaxed,” and “anxiety”
Blood sampling: Δ-9-THC and THC-COOH
End of each
day
Field sobriety test, Mini-Mental State Examination, vital signs, physician
evaluation
Last day Exit interview
Months 1, 3, 6 Assessment of cannabis use, desire, craving
Assessment for emergence of new psychiatric or medical problems

PANSS: Positive and Negative Syndrome Scale; CADSS: Clinician-Administered Dissociative Symptoms Scale; VAS: Visual Analog Scale; Δ-9-THC: Δ-9-tetrahydrocannibinol; THC-COOH: 11-nor-Δ-9-THC-9-COOH; HVLT: Hopkins Verbal Learning Test.